"Zoetis Plummets on Reports of Pet Arthritis Drug Side Effects"
Zoetis Inc. experienced a significant drop in its stock value following a news report raising safety concerns about the company's arthritis drugs for animals, leading to the biggest intraday decline in 17 months and positioning it as one of the worst performers in the S&P 500 Index on Friday.